Advertisement
Advertisement

HURA

HURA logo

TuHURA Biosciences, Inc. Common Stock

2.57
USD
Sponsored
+0.35
+15.77%
Jun 18, 15:57 UTC -4
Closed
exchange

After-Market

2.53

-0.04
-1.71%

HURA Earnings Reports

Positive Surprise Ratio

HURA beat 11 of 32 last estimates.

34%

Next Report

Date of Next Report
Aug 14, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.14
Implied change from Q1 26 (Revenue/ EPS)
--
/
+7.69%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-33.33%

TuHURA Biosciences, Inc. Common Stock earnings per share and revenue

On May 15, 2026, HURA reported earnings of -0.13 USD per share (EPS) for Q1 26, missing the estimate of -0.11 USD, resulting in a -10.83% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +10.39% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.14 USD, with revenue projected to reach -- USD, implying an increase of 7.69% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
logo
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
For Q1 2026, TuHURA Biosciences, Inc. Common Stock reported EPS of -$0.13, missing estimates by -10.83%, and revenue of $0.00, 0% as expectations.
The stock price moved up 10.39%, changed from $2.31 before the earnings release to $2.55 the day after.
The next earning report is scheduled for Aug 14, 2026.
Based on -- analysts, TuHURA Biosciences, Inc. Common Stock is expected to report EPS of -$0.14 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement